Join SCIRENT at ESC Congress 2023
Save the dates in your agenda and join us in Prague from 20 to 23 May 2023 for the ESC Heart Failure Association (HFA) annual meeting bringing together scientists, healthcare professionals, and other players from around the world. The world’s leading event covers the entire spectrum of heart failure, from prevention to diagnosis and treatment.
Meet our team in Prague to discover how SCIRENT, a specialized cardiovascular research organization, can help your business develop innovative therapies. SCIRENT works with biopharmaceutical and medical technology companies across all phases of development. As a specialty full-service contract research organization, we offer industry-leading solutions across a wide range of chronic and acute cardiovascular indications. We offer an excellent network of high-performing trial sites in Europe, regulatory consulting, and strong medical expertise to support the design and execution of your programs.
This event will also allow SCIRENT to showcase its new booth while presenting distinct advantages in conducting studies in Central and Eastern Europe.
More recent News
Germany Fast-Track Pathway for Early Clinical Development
Germany has significantly improved the attractiveness of early clinical development through the Medical Research Act (Medizinforschungsgesetz, MFG) to expedite the approval of mononational clinical trials.
Prof. Dr. Wilhelm Haverkamp Appointed Chief Medical Officer at SCIRENT
Berlin, 16. April 2026. SCIRENT announced the appointment of Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer (CMO), effective immediately. In this role, Prof. Haverkamp
SCIRENT to Participate in CSI Focus D-HF 2025 in Frankfurt
SCIRENT, a full-service cardiovascular Contract Research Organization (CRO) specializing in clinical studies for heart failure and cardiac devices, will participate in the upcoming CSI Focus